Delivery Order 36F79720D0189-36C26124N0511
Award Date 3/18/24
Potential Completion Date 4/18/24
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Talleyville, DE 19803, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order is for the drug PEMAZYRE and has a completion date of December 31, 2020. The contract was awarded on November 18, 2020 and utilizes Master Schedule contract FSS-61-IB, which provides pharmaceuticals and drugs to government agencies. The...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21 to Incyte Corporation, a global biopharmaceutical company. The $13,290.97 delivery order contract is for the drug Pemigatinib, which is used to treat certain types of cancer. The contract was awarded under Incyte's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, and has a firm fixed price. No set-aside...
- Incyte Corporation has been awarded a $12,811.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for PEMIGATINIB/PEMAZYRE 9MG TAB to be delivered to a location in Fresno, California by May 22, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB to supply pharmaceutical products and drugs in...
- Incyte Corporation was awarded a $13,290.97 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Pemigatinib tablets. The order was issued against Incyte's Pharmaceuticals and Drugs Federal Supply Schedule contract to fulfill a request for Pemazyre, an anti-cancer medication, with delivery to occur by March 2024. Incyte holds a Blanket Purchase Agreement valued at $3.75 million and a ten-year Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order contract to Incyte Corporation. Under the terms of the contract, Incyte will provide Pemigatinib to the VA network through January 2024. The contract was awarded against Incyte's Pharmaceuticals and Drugs schedule (FSS-61-IB) master agreement with the General Services Administration. Pemigatinib will be delivered to the VA network's location in Talleyville,...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21, is for the emergency provision of 4.5mg Pemigatinib tablets to treat eligible veterans. The $12,725.23 firm fixed price contract was awarded on June 13, 2023 to Incyte Corporation of Talleyville, Delaware and has a period of performance through July 13, 2023. No set-aside designation was applied...
- Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, which has no set aside designation and completion date of October 30, 2020, is for the provision of PEMAZYRE to treat patients. The firm fixed price order was awarded on October 5, 2020 under Incyte's master GSA Schedule contract vehicle. The place...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $12,725.23 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The firm fixed price order is for PEMAZYRE 9 MG tablets to fulfill requirements through September 30th, 2022. Place of performance will be Incyte Corporation's location in West Chester Township, Ohio. No set-aside designation was applied to this order to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725.23 delivery order to Incyte Corporation under the company's Pharmaceuticals and Drugs GSA Schedule contract. The delivery order is for PEMAZYRE/PEMIGATINIB 4.5MG tablets, to be delivered to a location in Talleyville, Delaware between September 25, 2023 and November 10, 2023. The contract has a firm fixed price and will provide cancer treatment medications to support VHA...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $63,626.15 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule. The firm fixed price order is for PEMAZYRE 13.5, with performance in West Haven, Connecticut and a completion date of April 10, 2022. The contract utilizes Master GSA Schedule FSS-61-IB and has no set-aside designation. Incyte will provide cancer treatment drugs to support...